Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 891-900 of 2916 for cancer

Edit search filters
  1. A Study To Evaluate The Effect Of Ripretinib On The Pharmacokinetics Of A CYP2C8 Probe Substrate In Patients With Advanced GIST

    Jacksonville, FL

  2. A Study Of THE-630 In Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

    Jacksonville, FL

  3. A Study Of PY314 In Subjects With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Phase 2 Study With TTI-622 And TTI-621 In Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)

    Rochester, MN

  5. A Study Of The Combination Of Talquetamab And Teclistamab In Participants With Relapsed Or Refractory Multiple Myeloma

    Rochester, MN

  6. Clinical Study Protocol For Cutaneous SCC For Immunocompromised Patients

    Rochester, MN

  7. A Study To Evaluate The Effect Of Canakinumab Or Pembrolizumab Given As Monotherapy Or In Combination As Neo-adjuvant Treatment For Subjects With Early Stages NSCLC

    Scottsdale/Phoenix, AZ

  8. Confirmatory Study Of Topical HyBryte™ Vs. Placebo For The Treatment Of CTCL (FLASH2)

    Scottsdale/Phoenix, AZ

  9. Testing The Use Of Chemotherapy After Surgery For High-Risk Pancreatic Neuroendocrine Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study of Pertuzumab Combined with High-Dose Trastuzumab for Patients who have Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer with Central Nervous System Progression After Radiation Therapy

    Jacksonville, FL

.

Mayo Clinic Footer